Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes
- 11 September 2004
- journal article
- research article
- Published by Elsevier BV in Biomaterials
- Vol. 26 (15), 2723-2732
- https://doi.org/10.1016/j.biomaterials.2004.07.047
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Drug targetingEuropean Journal of Pharmaceutical Sciences, 2000
- Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acidEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Preparation of avidin-labelled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA)International Journal of Pharmaceutics, 2000
- Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeuticsJournal of Controlled Release, 2000
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000
- Gene Transfer by DNA–Gelatin NanospheresArchives of Biochemistry and Biophysics, 1999
- Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer–doxorubicin conjugates directed against different T-cell surface antigensJournal of Controlled Release, 1998
- A Novel Biodegradable System Based on Gelatin Nanoparticles and Poly(lactic-co-glycolic acid) Microspheres for Protein and Peptide Drug DeliveryJournal of Pharmaceutical Sciences, 1997
- Monoclonal antibodies covalently coupled to polymethacrylic nanoparticles: in vitro specific targeting to human T lymphocytesInternational Journal of Pharmaceutics, 1987
- An improved method for covalent attachment of antibody to liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1982